FASN and non-small cell lung carcinoma: Li et al. [82] showed that SREBP inhibition by betulin, fatostatin, or 25-hydroxycholesterol in NSCLC cells downregulated the expression of FASN, SCD, and HMGCR genes, reducing the proportion of cholesterol and unsaturated FAs on the cell membrane.